Recordati S.p.A.
OTC: RCDTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Robert Koremans
- Employees
- 4,614
- Headquarters
- Milan, Italy
- IPO year
- 2010
- Market cap
- $11.8B
- Website
- https://www.ricoh.com
Loading RCDTF…
Loading profile data…Frequently asked questions about RCDTF
What does Recordati S.p.A. (RCDTF) do?
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The com...
Where does RCDTF trade?
Recordati S.p.A. (RCDTF) trades on the Other OTC.
What sector is RCDTF in?
Recordati S.p.A. (RCDTF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Recordati S.p.A.?
Robert Koremans is the chief executive officer of Recordati S.p.A. (RCDTF).
Where is Recordati S.p.A. headquartered?
Recordati S.p.A. is headquartered in Italy.
Does RCDTF pay a dividend?
Yes — Recordati S.p.A. (RCDTF) paid a trailing twelve-month dividend of USD 1.55 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did RCDTF go public?
Recordati S.p.A. (RCDTF) completed its initial public offering in 2010.